CN Patent

CN105085550B — 一类alk激酶抑制剂及其制备方法

Assigned to Jiangsu Huiju Pharmaceutical Co ltd · Expires 2017-05-24 · 9y expired

What this patent protects

本发明涉及一类ALK激酶抑制剂及其合成方法。

USPTO Abstract

本发明涉及一类ALK激酶抑制剂及其合成方法。

Drugs covered by this patent

ensartinib-hydrochloride (ENSARTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN105085550B
Jurisdiction: CN
Classification: —
Expires: 2017-05-24
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Huiju Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.